Ehrlichia ewingii infection delays spontaneous neutrophil apoptosis through stabilization of mitochondria

Journal of Infectious Diseases

Volumn 197, Issue 8, 2008, Pages 1110-1118

  Xiong, Qingming ^a   Bao, Weichao ^a   Ge, Yan ^a   Rikihisa, Yasuko ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CYCLOPHOSPHAMIDE; DOXYCYCLINE; MESSENGER RNA; PROTEIN BCL 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BACTERIUM; CELL STRUCTURE; CELL SURVIVAL; CONTROLLED STUDY; DOG; EHRLICHIA EWINGII; EHRLICHIOSIS; ENZYME ACTIVITY; EX VIVO STUDY; FEMALE; IN VIVO STUDY; MALE; MEMBRANE POTENTIAL; MITOCHONDRION; NEUTROPHIL; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; APOPTOSIS; CASPASE 3; DOG DISEASES; DOGS; EHRLICHIA; EHRLICHIOSIS; FEMALE; FLOW CYTOMETRY; HISTOCYTOCHEMISTRY; MALE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; NEUTROPHILS; PROTO-ONCOGENE PROTEINS C-BCL-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPECIFIC PATHOGEN-FREE ORGANISMS;

EID: 42549101393     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/533457     Document Type: Article

References (50)

1. Buller RS, Arens M, Hmiel SP, et al. Ehrlichia ewingii, a newly recognized agent of human ehrlichiosis. N Engl J Med 1999; 341:148-55.
2. Gusa AA, Buller RS, Storch GA, et al. Identification of a p28 gene in Ehrlichia ewingii: evaluation of gene for use as a target for a species-specific PCR diagnostic assay. J Clin Microbiol 2001; 39:3871-6.
3. Ewing SA, Roberson WR, Buckner RG, Hayat CS. A new strain of Ehrlichia canis. J Am Vet Med Assoc 1971; 159:1771-4.
4. Anderson BE, Greene CE, Jones DC, Dawson JE. Ehrlichia ewingii sp. nov., the etiologic agent of canine granulocytic ehrlichiosis. Int J Syst Bacteriol 1992; 42:299-302.
5. Liddell AM, Stockham SL, Scott MA, et al. Predominance of Ehrlichia ewingii in Missouri dogs. J Clin Microbiol 2003; 41:4617-22.
6. Goldman EE, Breitschwerdt EB, Grindem CB, Hegarty BC, Walls JJ, Dumler JS. Granulocytic ehrlichiosis in dogs from North Carolina and Virginia. J Vet Intern Med 1998; 12:61-70.
7. Murphy GL, Ewing SA, Whitworth LC, Fox JC, Kocan AA. A molecular and serologic survey of Ehrlichia canis, E. chaffeensis, and E. ewingii in dogs and ticks from Oklahoma. Vet Parasitol 1998; 79:325-39.
8. Dawson JE, Biggie KL, Warner CK, et al. Polymerase chain reaction evidence of Ehrlichia chaffeensis, an etiologic agent of human ehrlichiosis, in dogs from southeast Virginia. Am J Vet Res 1996; 57:1175-9.
9. Ndip LM, Ndip RN, Esemu SN, et al. Ehrlichial infection in Cameroonian canines by Ehrlichia canis and Ehrlichia ewingii. Vet Microbiol 2005; 111:59-66.
10. Stockham SL, Tyler JW, Schmidt DA, Curtis KS. Experimental transmission of granulocytic ehrlichial organisms in dogs. Vet Clin Pathol 1990; 19:99-104.
11. Stockham SL, Schmidt DA, Curtis KS, Schauf BG, Tyler JW, Simpson ST. Evaluation of granulocytic ehrlichiosis in dogs of Missouri, including serologic status to Ehrlichia canis, Ehrlichia equi and Borrelia burgdorferi. Am J Vet Res 1992; 53:63-8.
12. Yabsley MJ, Varela AS, Tate CM, et al. Ehrlichia ewingii infection in white-tailed deer (Odocoileus virginianus). Emerg Infect Dis 2002; 8:668-71.
13. Dawson JE, Anderson BE, Fishbein DB, et al. Isolation and characterization of an Ehrlichia sp. from a patient diagnosed with human ehrlichiosis. J Clin Microbiol 1991; 29:2741-5.
14. Dawson JE, Rikihisa Y, Ewing SA, Fishbein DB. Serologic diagnosis of human ehrlichiosis using two Ehrlichia canis isolates. J Infect Dis 1991; 163:564-7.
15. Goodman JL, Nelson C, Vitale B, et al. Direct cultivation of the causative agent of human granulocytic ehrlichiosis. N Engl J Med 1996; 334:209-15.
16. Munderloh UG, Jauron SD, Fingerle V, et al. Invasion and intracellular development of the human granulocytic ehrlichiosis agent in tick cell culture. J Clin Microbiol 1999; 37:2518-24.
17. Munderloh UG, Lynch MJ, Herron MJ, et al. Infection of endothelial cells with Anaplasma marginale and A. phagocytophilum. Vet Microbiol 2004; 101:53-64.
18. Kobayashi SD, Voyich JM, DeLeo FR. Regulation of the neutrophilmediated inflammatory response to infection. Microbes Infect 2003; 5:1337-44.
19. Akgul C, Moulding DA, Edwards SW. Molecular control of neutrophil apoptosis. FEBS Lett 2001; 487:318-22.
20. DeLeo FR. Modulation of phagocyte apoptosis by bacterial pathogens. Apoptosis 2004; 9:399-413.
21. Yoshiie K, Kim HY, Mott J, Rikihisa Y. Intracellular infection by the human granulocytic ehrlichiosis agent inhibits human neutrophil apoptosis. Infect Immun 2000; 68:1125-33.
22. Scaife H, Woldehiwet Z, Hart CA, Edwards SW. Anaplasma phagocytophilum reduces neutrophil apoptosis in vivo. Infect Immun 2003; 71:1995-2001.
23. van Zandbergen G, Gieffers J, Kothe H, et al. Chlamydia pneumoniae multiply in neutrophil granulocytes and delay their spontaneous apoptosis. J Immunol 2004; 172:1768-76.
24. Aga E, Katschinski DM, van Zandbergen G, et al. Inhibition of the spontaneous apoptosis of neutrophil granulocytes by the intracellular parasite Leishmania major. J Immunol 2002; 169:898-905.
25. Ge Y, Yoshiie K, Kuribayashi F, Lin M, Rikihisa Y. Anaplasma phagocytophilum inhibits human neutrophil apoptosis via upregulation of bfl-1, maintenance of mitochondrial membrane potential and prevention of caspase 3 activation. Cell Microbiol 2005; 7:29-38.
26. Fossati G, Moulding DA, Spiller DG, Moots RJ, White MR, Edwards SW. The mitochondrial network of human neutrophils: role in chemotaxis, phagocytosis, respiratory burst activation, and commitment to apoptosis. J Immunol 2003; 170:1964-72.
27. Maianski NA, Geissler J, Srinivasula SM, Alnemri ES, Roos D, Kuijpers TW. Functional characterization of mitochondria in neutrophils: a role restricted to apoptosis. Cell Death Differ 2004; 11:143-53.
28. Dawson JE, Stallknecht DE, Howerth EW, et al. Susceptibility of white-tailed deer (Odocoileus virginianus) to infection with Ehrlichia chaffeensis, the etiologic agent of human ehrlichiosis. J Clin Microbiol 1994; 32:2725-8.
29. Zhi N, Ohashi N, Rikihisa Y. Multiple p44 genes encoding major outer membrane proteins are expressed in the human granulocytic ehrlichiosis agent. J Biol Chem 1999; 274:17828-36.
30. Wen B, Rikihisa Y, Mott JM, et al. Comparison of nested PCR with immunofluorescent-antibody assay for detection of Ehrlichia canis infection in dogs treated with doxycycline. J Clin Microbiol 1997; 35:1852-5.
31. Reardon MJ, Pierce KR. Acute experimental canine ehrlichiosis. II. Sequential reaction of the hemic and lymphoreticular system of selectively immunosuppressed dogs. Vet Pathol 1981; 18:384-95.
32. Xiong Q, Wang X, Rikihisa Y. High-cholesterol diet facilitates Anaplasma phagocytophilum infection and up-regulates macrophage inflammatory protein-2 and CXCR2 expression in apolipoprotein E-deficient mice. J Infect Dis 2007; 195:1497-503.
33. Reers M, Smith TW, Chen LB. J-aggregate formation of a carbocyanine as a quantitative fluorescent indicator of membrane potential. Biochemistry 1991; 30:4480-6.
34. Pongracz J, Webb P, Wang K, Deacon E, Lunn OJ, Lord JM. Spontaneous neutrophil apoptosis involves caspase 3-mediated activation of protein kinase C-delta. J Biol Chem 1999; 274:37329-34.
35. Sano J, Oguma K, Kano R, Hasegawa A. Characterization of canine caspase-3. J Vet Med Sci 2004; 66:563-7.
36. Kumaraguruparan R, Karunagaran D, Balachandran C, Manohar BM, Nagini S. Of humans and canines: a comparative evaluation of heat shock and apoptosis-associated proteins in mammary tumors. Clin Chim Acta 2006; 365:168-76.
37. Cory S, Adams JM. The Bcl2 family: regulators of the cellular life-ordeath switch. Nat Rev Cancer 2002; 2:647-56.
38. Oguma K, Sano J, Kano R, Watari T, Hasegawa A. In vitro effect of recombinant human tumor necrosis factor-alpha on canine neutrophil apoptosis. Res Vet Sci 2006; 80:162-6.
39. Oguma K, Sano J, Kano R, Watari T, Moritomo T, Hasegawa A. In vitro effect of recombinant human granulocyte colony-stimulating factor on canine neutrophil apoptosis. Vet Immunol Immunopathol 2005; 108:307-14.
40. Sano J, Oguma K, Kano R, Yazawa M, Tsujimoto H, Hasegawa A. High expression of Bcl-xL in delayed apoptosis of canine neutrophils induced by lipopolysaccharide. Res Vet Sci 2005; 78:183-7.
41. Dumler JS, Rikihisa Y, Dasch GA. Ehrlicihia, the Proteobacteria, part C. In: Brenner K, Krieg NR, Staley JT, Garrity GM, eds. Bergey's manual of systematic bacteriology. 2nd ed. Vol 2. New York: Springer, 2005:125-31.
42. Zhang JZ, Sinha M, Luxon BA, Yu XJ. Survival strategy of obligately intracellular Ehrlichia chaffeensis: novel modulation of immune response and host cell cycles. Infect Immun 2004; 72:498-507.
43. Ge Y, Rikihisa Y. Anaplasma phagocytophilum delays spontaneous human neutrophil apoptosis by modulation of multiple apoptotic pathways. Cell Microbiol 2006; 8:1406-16.
44. Marder W, McCune WJ. Advances in immunosuppressive therapy. Semin Respir Crit Care Med 2007; 28:398-417.
45. Jozsef L, Khreiss T, Filep JG. CpG motifs in bacterial DNA delay apoptosis of neutrophil granulocytes. Faseb J 2004; 18:1776-8.
46. Into T, Shibata K. Apoptosis signal-regulating kinase 1-mediated sustained p38 mitogen-activated protein kinase activation regulates mycoplasmal lipoprotein- and staphylococcal peptidoglycan-triggered Toll-like receptor 2 signalling pathways. Cell Microbiol 2005; 7:1305-17.
47. Power CP, Wang JH, Manning B, et al. Bacterial lipoprotein delays apoptosis in human neutrophils through inhibition of caspase-3 activity: regulatory roles for CD14 and TLR-2. J Immunol 2004; 173:5229-37.
48. Kim JS, Kim JM, Jung HC, Song IS, Kim CY. Inhibition of apoptosis in human neutrophils by Helicobacter pylori water-soluble surface proteins. Scand J Gastroenterol 2001; 36:589-600.
49. Bazzocchi C, Comazzi S, Santoni R, Bandi C, Genchi C, Mortarino M. Wolbachia surface protein (WSP) inhibits apoptosis in human neutrophils. Parasite Immunol 2007; 29:73-9.
50. Mackall CL, Fleisher TA, Brown MR, et al. Lymphocyte depletion during treatment with intensive chemotherapy for cancer. Blood 1994; 84:2221-8.